C

CATX

CATX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
23%Bearish
Buy/Sell Ratio100% buys
BearishBullish
CATX Live QuoteReal-time
$0.78
$1.52(-65.91%)1M
Day Range$0.73 – $0.81
Open$0.81
Previous Close$0.78
Volume1.85M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$94.20M
P/E Ratio (TTM)24.5
Forward P/E25.7
EPS (TTM)$-1.25
Price to Book0.4
Dividend Yield0.65%
Beta (Volatility)1.99
IndustryMEDICAL DEVICES
52-Week RangeCurrent: $0.78 (1%)
Low: $0.72High: $6.16
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$9.43-93.7% upside

Insider Buys

3

$67K

Insider Sales

0

$0

Total Volume

$67K

13 transactions

Net Activity

+$67K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys10 sells

$11.94B total

P
2

Puhlmann Markus

Chief Medical Officer

1 buys0 sells

$35K total

W
3

Williamson Robert F III

Dir

2 buys0 sells

$33K total

Trading History
CATX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 18, 2026

2 days ago

Williamson Robert F III

Dir

Director
Buy15.0K$0.80$12K

Nov 17, 2026

3 days ago

Williamson Robert F III

Dir

Director
Buy25.0K$0.84$21K

Nov 11, 2026

1 weeks ago

Puhlmann Markus

Chief Medical Officer

C-Level
Buy41.0K$0.84$35K

Sep 3, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.27M$-247932.00$0

Sep 2, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.52M$-42129.00$0

Aug 31, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.56M$-113914.00$0

Sep 1, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.56M$-35769.00$0

Nov 13, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell59.8K$11000.00$657.80M

Nov 12, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell118.8K$9498.00$1.13B

Mar 31, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell188.3K$23475.00$4.42B

Mar 28, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell87.7K$26676.00$2.34B

Dec 4, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell26.0K$25975.00$674.70M

Nov 25, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell433.7K$6266.00$2.72B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
CATX Buy Conviction100%
Industry Rank#490 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

CATX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. CATX ranks #490 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for CATX

Over the last 90 days, corporate insiders at CATX (CATX) engaged in a total of 13 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $67K.

The net insider activity for CATX shows a net buying bias of $67K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 188.3K shares valued at $4.42B on Mar 31, 2025.

Live Market News & Developments
Aggregated real-time headlines for CATX (CATX)
6 updates

At $0.80 a share, the RFW3 Revocable Trust bought 15,000 shares of Perspective Therapeutics (CATX).

Stock Titan14h ago

Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?

Yahoo Finance126d ago

Perspective Therapeutics director buys $12,000 in company stock By Investing.com

Investing.com UK14h ago

$CATX Stock Is Down 27% Today. Here's What We See in Our Data.

Moomoo27d ago

CATX - Perspective Therapeutics Inc Stock Price and Quote

Finviz175d ago

$CATX stock is down 10% today. Here's what we see in our data.

Quiver Quantitative16d ago

FAQs About CATX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for CATX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for CATX is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 3 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for CATX is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.